Thrombophlebitis was the most common adverse reaction associated with intravenous amiodarone, at a rate of 8% among 550 patients, in a metaanalysis of 18 random-controlled
trials of patients with atrial fibrillation who received intravenous amiodarone.
12 In a retrospective review by Mowry and Hartman3 of 339 hospitalized patients who had
received intravenous amiodarone, the incidence of thrombophlebitis was 10.6%